Compared to lung fibroblasts isolated from wild-type mice treated with bleomycin (common drug for inducing pulmonary fibrosis), lung fibroblasts isolated from bleomycin-treated C/EBPβ null mice exhibit lower α-SMA levels and greater proliferation ability [39]. Here, CEBPB is linked to pulmonary fibrosis.